369 related articles for article (PubMed ID: 32883197)
1. Identification of Novel Phyto-chemicals from Ocimum basilicum for the Treatment of Parkinson's Disease using In Silico Approach.
Mubashir N; Fatima R; Naeem S
Curr Comput Aided Drug Des; 2020; 16(4):420-434. PubMed ID: 32883197
[TBL] [Abstract][Full Text] [Related]
2. Exploration of phytochemicals for inhibition of monoamine oxidase-A induced cancer using molecular docking studies.
Zaib N; Naim A; Naeem S
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1829-1834. PubMed ID: 31680079
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents.
Agrawal N; Mishra P
Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360
[TBL] [Abstract][Full Text] [Related]
4. Ligand based screening of chemical constituents from African medicinal plants for the identification of MAOB inhibitors.
Fatima R; Naim A; Naeem S
Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1207-1213. PubMed ID: 31303592
[TBL] [Abstract][Full Text] [Related]
5. Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug.
Pflüger P; Pereira P; Loza MI; Brea J; Viña D; Kumar A; Fontenla JA
Eur J Pharmacol; 2021 Sep; 906():174276. PubMed ID: 34174267
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
[TBL] [Abstract][Full Text] [Related]
7. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.
Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H
ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824
[TBL] [Abstract][Full Text] [Related]
8. Performance of Force-Field- and Machine Learning-Based Scoring Functions in Ranking MAO-B Protein-Inhibitor Complexes in Relevance to Developing Parkinson's Therapeutics.
Murugan NA; Muvva C; Jeyarajpandian C; Jeyakanthan J; Subramanian V
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081086
[TBL] [Abstract][Full Text] [Related]
9. DFT, ADME studies and evaluation of the binding with HSA and MAO-B inhibitory potential of protoberberine alkaloids from Guatteria friesiana: theoretical insights of promising candidates for the treatment of Parkinson's disease.
Tananta VL; Costa EV; Mary YS; Mary YS; S Al-Otaibi J; Costa RA
J Mol Model; 2023 Nov; 29(11):353. PubMed ID: 37907772
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design and analysis of MAO-B inhibitors for Parkinson's disease: using in silico approaches.
Kare P; Bhat J; Sobhia ME
Mol Divers; 2013 Feb; 17(1):111-22. PubMed ID: 23325357
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson's disease treatment.
Crisan L; Istrate D; Bora A; Pacureanu L
Mol Divers; 2021 Aug; 25(3):1775-1794. PubMed ID: 33237524
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
13. New role for crinamine as a potent, safe and selective inhibitor of human monoamine oxidase B: In vitro and in silico pharmacology and modeling.
Naidoo D; Roy A; Slavětínská LP; Chukwujekwu JC; Gupta S; Van Staden J
J Ethnopharmacol; 2020 Feb; 248():112305. PubMed ID: 31639490
[TBL] [Abstract][Full Text] [Related]
14. Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer's Treatment: A Computational Strategy.
Jabir NR; Rehman MT; Tabrez S; Alserihi RF; AlAjmi MF; Khan MS; Husain FM; Ahmed BA
Curr Pharm Des; 2021; 27(20):2425-2434. PubMed ID: 33634754
[TBL] [Abstract][Full Text] [Related]
15. Preliminary studies of berberine and its semi-synthetic derivatives as a promising class of multi-target anti-parkinson agents.
Ribaudo G; Zanforlin E; Canton M; Bova S; Zagotto G
Nat Prod Res; 2018 Jun; 32(12):1395-1401. PubMed ID: 28691859
[TBL] [Abstract][Full Text] [Related]
16. MAO inhibiting phytochemicals from the roots of
Bhattacharjee M; Manoharan S; Sathisaran U; Tamatam A; Perumal E
J Biomol Struct Dyn; 2024 May; 42(8):3887-3905. PubMed ID: 37243713
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
[TBL] [Abstract][Full Text] [Related]
18. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
[TBL] [Abstract][Full Text] [Related]
19. Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors.
Pisani L; Barletta M; Soto-Otero R; Nicolotti O; Mendez-Alvarez E; Catto M; Introcaso A; Stefanachi A; Cellamare S; Altomare C; Carotti A
J Med Chem; 2013 Mar; 56(6):2651-64. PubMed ID: 23437843
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic, Molecular and Computational Aspects of Novel Monoamine Oxidase (MAO) Inhibitors.
Ramesh M; Dokurugu YM; Thompson MD; Soliman ME
Comb Chem High Throughput Screen; 2017; 20(6):492-509. PubMed ID: 28294055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
